Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Conventional versus drug-eluting beads chemoembolization for infiltrative hepatocellular carcinoma: a comparison of efficacy and safety

Fig. 3

Tumor response at 1 month after the first TACE session. The objective response rate (ORR) (a) and disease control rate (DCR) (b) are shown. Note: CR, complete response; PR, partial response; SD, stable disease; PD, progressive disease; DEB-TACE, drug-eluting bead transarterial chemoembolization; cTACE, conventional transarterial chemoembolization; ECOG ps, Eastern Cooperative Oncology Group performance status; PVTT, portal venous tumor thrombus; APS, arterioportal shunt

Back to article page